Impressive Results for Cilta-Cel to Treat Patients With Relapsed/Refractory Multiple Myeloma
According to a recent report in Cancer Network, the results from CARTITUDE-1 were well received. CARTITUDE-1 is a phase 1b/2 clinical trial of the CAR T-cell treatment, Cilta-Cel, for the…